Saudi Journal of Gastroenterology
Home About us Instructions Ahead of print Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 899 
IN FOCUS
Year : 2007  |  Volume : 13  |  Issue : 3  |  Page : 147-149

Fibroscan® : A noninvasive test of liver fibrosis assessment


Gastroenterology Division, Medical Department, King Fahad General Hospital, PO Box 50564, Jeddah 21533, Saudi Arabia

Correspondence Address:
Abdullah S Al-Ghamdi
Gastroenterology Division, Medical Department, King Fahad General Hospital, PO Box 50564, Jeddah 21533
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1319-3767.33470

Rights and Permissions

Determination of the extent of progress of hepatic fibrosis is important in clinical practice, where it may reflect the severity of liver disease and predict response to treatment. Percutaneous liver biopsy is the gold standard for grading and staging of liver disease. However, liver biopsy is an invasive procedure with certain unavoidable risks and complications. Several methods have been studied in an attempt to reach a diagnosis of cirrhosis by noninvasive means. Fibroscan® has been designed to quantify liver fibrosis by means of elastography and found to have reasonably good sensitivity and specificity patterns, especially in patients with advanced fibrosis and can be used as an alternative to liver biopsy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed22083    
    Printed310    
    Emailed7    
    PDF Downloaded1290    
    Comments [Add]    
    Cited by others 1    

Recommend this journal